AHR and obesity due to melanocortin 4 receptor deficiency: In addition to conferring resistance to obesity, global AHR deficiency was reported to protect mice against other HFD-induced disorders of the metabolic syndrome including visceral fat accumulation and inflammation, insulin resistance, glucose intolerance, and steatohepatitis; interestingly, body weight gain on a standard diet was not modified [9].